Clinical Trials
Clinical Trial
Feb 19, 2012 06:57AM
Feb 16, 2012 02:54PM
Post Stroke Language Impairment Ups Costs
Patients who develop language impairment during the first year after a stroke may need to open their pocketbook a little wider. Language impairment appears to add substantial costs to post-stroke care.
Feb 15, 2012 02:06PM
Women With PAD Undertreated But Higher Risk
Peripheral artery disease (PAD) affects men and women nearly equally. Yet women are still more likely to go undiagnosed, even though the serious circulatory disease can nearly triple their risk of stroke and heart attack.
Feb 12, 2012 07:02PM
Heartbeat Vibrations Can Power Pacemakers
Scientists have long searched for an alternative to surgically replacing batteries in a pacemaker, which helps regulate an irregular heartbeat. A prototype draws its energy from a surprising source.
Feb 12, 2012 10:06AM
MS Drug Shows Promise to Treat Heart Condition
A multiple sclerosis drug may work double duty. It has been shown in a lab study to prevent and even reverse one of the leading causes of heart attack.
Feb 10, 2012 03:39PM
A common story in cancer treatment is of specialized drugs that work great initially, but over time the cancer becomes resistant to the drug. Finding out why this happens has become paramount for scientists.
Feb 10, 2012 07:33AM
The Genetic Link Between Men and Heart Disease
Men may be at an added genetic risk of developing heart disease. That's because the Y chromosome, a portion of DNA that only men have, appears to play a role in inheriting coronary artery disease.
Feb 09, 2012 07:17AM
Taking both clopidogrel (Plavix) and aspirin together does not appear to cut the risk of recurrent deep brain strokes. Research suggests it also increases the risk of bleeding events or dying.
Feb 09, 2012 01:01AM
Trying to Stamp Out More Meningitis
Another vaccine may be on the horizon to protect against additional forms of bacterial meningitis - and it appears to get along with other vaccines too.
Feb 07, 2012 01:32PM
One Lung Cancer Drug - Multiple Targets
Cancer biology overlaps frequently, and some drugs designed for a specific mutation may have multiple uses, as one study shows.
Feb 06, 2012 01:49PM
Merck, known as MSD outside the United States and Canada, provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
Click the following links for more information about clinical trails.
General Information
- What is ClinicalTrials.gov?
- How do I sign up for a clinical trial listed on ClinicalTrials.gov?
- Does ClinicalTrials.gov provide advice for specific medical conditions?
- What makes ClinicalTrials.gov different from other clinical trials resources?
- How is study information submitted for listing on ClinicalTrials.gov?
- How do I link to ClinicalTrials.gov from my Web site?
- How can I find the results of a clinical trial?
- How do I cite a study from ClinicalTrials.gov?
- How do I access ClinicalTrials.gov and is there a charge?
- Is ClinicalTrials.gov accessible to users with disabilities?
Understanding Clinical Trials
- What is a clinical trial?
- What is a protocol?
- What is "Expanded Access"?
- How do I find information on Expanded Access Studies in ClinicalTrials.gov?
- What are clinical trial phases?
- What protections are there for participating in a clinical trial?
- What is informed consent?
- Who can participate in a clinical trial?
- Who sponsors clinical trials and where do they take place?
- What are the benefits and risks of participating in a clinical trial?
- Can I leave a clinical trial after it has begun?
|
|
 |
 |
Privacy Policy Site Policies About Contact Us Pharmacy Affiliate Pharmacist Contributors Medical Advisory Board